BRIEF-Theratechnologies announces commercialization agreement for Tesamorelin in Spain and Portugal
Sept 1 (Reuters) -
* Theratechnologies announces commercialization agreement for Tesamorelin in Spain and Portugal
* Theratechnologies-will manufacture and supply EGRIFTA to Praxis at a predetermined transfer price
* Theratechnologies-concluded agreements With Praxis Pharmaceutical, S.A. and its unit for distribution,commercialization of EGRIFTA in Spain and Portugal
* Theratechnologies-Praxis to conduct regulatory activities necessary for marketing approval for EGRIFTA in Spain ,Portugal
* Theratechnologies-Praxis will distribute EGRIFTA through named patient sales programs Source text for Eikon:
© Thomson Reuters 2017 All rights reserved.